Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
58
CNRD Quote, Financials, Valuation and Earnings
Last price:
$19.99
Seasonality move
:
1.04%
Day range:
$18.53 - $19.99
52-week range:
$8.75 - $19.52
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.30x
P/B ratio:
0.70x
Volume:
100
Avg. volume:
6K
1-year change:
110.42%
Market cap:
$100.3M
Revenue:
--
EPS (TTM):
--
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $309M | $263.8M | $164.4M | $189.1M | $182.3M | |
| Revenue Growth (YoY) | 1.87% | -14.63% | -37.68% | 15.04% | -3.61% | |
| Cost of Revenues | $269.2M | $248.9M | $160.9M | $188.4M | $182.9M | |
| Gross Profit | $39.8M | $14.9M | $3.5M | $717K | -$585K | |
| Gross Profit Margin | 12.88% | 5.65% | 2.14% | 0.38% | -0.32% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $8.6M | $7.2M | $6.5M | $6.2M | $5.7M | |
| Other Inc / (Exp) | $235K | -$1.4M | $555K | $542K | $7.5M | |
| Operating Expenses | $8.6M | $7.2M | $6.5M | $6.2M | $5.7M | |
| Operating Income | $31.3M | $7.8M | -$3M | -$5.4M | -$6.3M | |
| Net Interest Expenses | $11K | $82K | $44K | $505K | $480K | |
| EBT. Incl. Unusual Items | $31.5M | $6.3M | -$2.4M | -$5.4M | $796K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $8.7M | -$4.3M | -$755K | -$3.3M | $598K | |
| Net Income to Company | $22.8M | $10.6M | -$1.7M | -$2.1M | $198K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $22.8M | $10.6M | -$1.7M | -$2.1M | $198K | |
| Basic EPS (Cont. Ops) | $3.84 | $1.86 | -$0.33 | -$0.42 | $0.04 | |
| Diluted EPS (Cont. Ops) | $3.84 | $1.86 | -$0.33 | -$0.42 | $0.04 | |
| Weighted Average Basic Share | $6M | $5.7M | $5.2M | $5.1M | $5M | |
| Weighted Average Diluted Share | $6M | $5.7M | $5.2M | $5.1M | $5M | |
| EBITDA | $37.2M | $12.7M | $4.7M | $2.6M | $8.2M | |
| EBIT | $31.5M | $6.4M | -$2.4M | -$4.9M | $1.3M | |
| Revenue (Reported) | $309M | $263.8M | $164.4M | $189.1M | $182.3M | |
| Operating Income (Reported) | $31.3M | $7.8M | -$3M | -$5.4M | -$6.3M | |
| Operating Income (Adjusted) | $31.5M | $6.4M | -$2.4M | -$4.9M | $1.3M | |
| Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $43M | $60.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -14.41% | 36.97% | |
| Cost of Revenues | -- | -- | -- | $48.2M | $63.4M | |
| Gross Profit | -- | -- | -- | -$5.2M | -$2.7M | |
| Gross Profit Margin | -- | -- | -- | -12.02% | -4.44% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $2.1M | $1.7M | |
| Other Inc / (Exp) | -- | -- | -- | $119K | $152K | |
| Operating Expenses | -- | -- | -- | $2.1M | $1.7M | |
| Operating Income | -- | -- | -- | -$7.2M | -$4.4M | |
| Net Interest Expenses | -- | -- | -- | $58K | $65K | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$7.2M | -$4.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$1.9M | -$1.1M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$5.3M | -$3.2M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$1.06 | -$0.63 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$1.06 | -$0.63 | |
| Weighted Average Basic Share | -- | -- | -- | $5M | $5M | |
| Weighted Average Diluted Share | -- | -- | -- | $5M | $5M | |
| EBITDA | -- | -- | -- | -$7.1M | -$4.3M | |
| EBIT | -- | -- | -- | -$7.1M | -$4.3M | |
| Revenue (Reported) | -- | -- | -- | $43M | $60.7M | |
| Operating Income (Reported) | -- | -- | -- | -$7.2M | -$4.4M | |
| Operating Income (Adjusted) | -- | -- | -- | -$7.1M | -$4.3M | |
| Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $175.1M | $191.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | $183.3M | $203M | |
| Gross Profit | -- | -- | -- | -$8.3M | -$11.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | $6.2M | $6.5M | |
| Other Inc / (Exp) | -- | -- | -- | $7.7M | $297K | |
| Operating Expenses | -- | -- | -- | $6.2M | $6.5M | |
| Operating Income | -- | -- | -- | -$14.5M | -$18M | |
| Net Interest Expenses | -- | -- | -- | $422K | $372K | |
| EBT. Incl. Unusual Items | -- | -- | -- | -$7.2M | -$18.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -$1.5M | -$4.5M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -$5.7M | -$13.6M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -$1.14 | -$2.71 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -$1.14 | -$2.71 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -$1.7M | -$14.3M | |
| EBIT | -- | -- | -- | -$6.8M | -$17.7M | |
| Revenue (Reported) | -- | -- | -- | $175.1M | $191.5M | |
| Operating Income (Reported) | -- | -- | -- | -$14.5M | -$18M | |
| Operating Income (Adjusted) | -- | -- | -- | -$6.8M | -$17.7M | |
| Period Ending | 2021-07-18 | 2022-07-18 | 2023-07-18 | 2024-07-18 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $68.6M | $46.9M | $11.9M | $29.5M | $31.7M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $24.1M | $10.1M | $7.8M | $29.1M | $27.3M | |
| Inventory | $13.3M | $3M | $4.8M | $1M | $3.5M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.2M | $4.4M | $6.8M | $5.8M | $4.5M | |
| Total Current Assets | $129.4M | $94.2M | $92M | $94.1M | $96.1M | |
| Property Plant And Equipment | $61.5M | $72.7M | $72.5M | $67.4M | $61.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $94K | $84K | $3.3M | |
| Total Assets | $190.9M | $167M | $164.5M | $161.5M | $160.5M | |
| Accounts Payable | $9.9M | $9.2M | $10M | $11.5M | $8.7M | |
| Accrued Expenses | $12.7M | $6M | $4M | $3.4M | $5M | |
| Current Portion Of Long-Term Debt | -- | -- | $1.5M | $1.5M | $1.5M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $49.8M | $33M | $25.9M | $32.1M | $33.6M | |
| Long-Term Debt | -- | -- | $13.4M | $11.9M | $10.4M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $59M | $42.6M | $48.7M | $49.6M | $48.4M | |
| Common Stock | $73K | $73K | $73K | $73K | $73K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $131.8M | $124.4M | $115.8M | $111.9M | $112.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $131.8M | $124.4M | $115.8M | $111.9M | $112.1M | |
| Total Liabilities and Equity | $190.9M | $167M | $164.5M | $161.5M | $160.5M | |
| Cash and Short Terms | $68.6M | $46.9M | $11.9M | $29.5M | $31.7M | |
| Total Debt | -- | -- | $14.9M | $13.4M | $11.9M | |
| Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $29.6M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $37.3M | |
| Inventory | -- | -- | -- | -- | $2.1M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | $10.3M | |
| Total Current Assets | -- | -- | -- | -- | $105.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | $43.2M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | $985K | |
| Total Assets | -- | -- | -- | -- | $150.1M | |
| Accounts Payable | -- | -- | -- | -- | $9.2M | |
| Accrued Expenses | -- | -- | -- | -- | $2.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $1.5M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | -- | -- | $61.5M | |
| Long-Term Debt | -- | -- | -- | -- | $3.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $67M | |
| Common Stock | -- | -- | -- | -- | $73K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | $83.1M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $150.1M | |
| Cash and Short Terms | -- | -- | -- | -- | $29.6M | |
| Total Debt | -- | -- | -- | -- | $4.8M | |
| Period Ending | 2014-12-31 | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2018-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $22.8M | $10.6M | -$1.7M | -$2.1M | $198K | |
| Depreciation & Amoritzation | $5.7M | $6.3M | $7.1M | $7.5M | $6.9M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | $4.9M | $13.9M | $2.4M | -$21.3M | $1.8M | |
| Change in Inventories | -$9.9M | $4.5M | -$782K | $2.2M | -$7.6M | |
| Cash From Operations | $33.9M | $13.9M | -$36.2M | $23.4M | $4.6M | |
| Capital Expenditures | $9.9M | $17.5M | $6.9M | $2.5M | $785K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$9.9M | -$17.5M | -$6.9M | -$2.5M | -$780K | |
| Dividends Paid (Ex Special Dividend) | -$5.9M | -$5.7M | -$2.1M | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $15M | -- | -- | |
| Long-Term Debt Repaid | -$1.2M | -- | -$125K | -$1.5M | -$1.5M | |
| Repurchase of Common Stock | -$3.2M | -$12.4M | -$4.8M | -$1.8M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$10.3M | -$18.1M | $8M | -$3.3M | -$1.5M | |
| Beginning Cash (CF) | $54.9M | $68.6M | $46.9M | $11.9M | $29.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $13.7M | -$21.7M | -$35M | $17.6M | $2.3M | |
| Ending Cash (CF) | $68.6M | $46.9M | $11.9M | $29.5M | $31.7M | |
| Levered Free Cash Flow | $24M | -$3.6M | -$43.1M | $20.9M | $3.8M | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | $546K | $365K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Get CNRD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CNRD
Sector
P/E ratio
--
18.58x
PEG ratio
--
0.25x
P/B ratio
0.70x
1.75x
Price / LTM sales
0.30x
0.94x
Growth Metrics
CNRD
Sector
Revenue growth
--
1.98%
Earnings growth
--
2.46%
Revenue (5-year growth)
--
4.35%
Earnings forecast
--
$0.40
Profitability
CNRD
Sector
Profitability FY 2025
--
$393.9M
Return on invested capital
--
5.32%
Return on assets
--
3.49%
Return on equity
--
8.55%
Earnings Date
Last Earnings Date
May
15
Next Earnings Date
Aug
14
Estimated Next Earnings Date
Aug
14
Balance Sheet
CNRD
Sector
Total cash
--
$154.3M
Short term investments
--
$35.5M
Total assets
--
$1.7B
Long term debt
--
$252.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
